Optic pathway gliomas: A review

Neurosurgical Focus

Volumn 23, Issue 5, 2007, Pages 1-8

  Binning, M J ^a   Liu, J K ^a   Kestle, J R W ^b   Brockmeyer, D L ^a   Walker, M L ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Hypothalamus glioma; Neurofibromatosis Type 1; Optic pathway glioma

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT THERAPY; CHILD; DIAGNOSTIC IMAGING; FEMALE; GLIOMA; HUMAN; MALE; METHODOLOGY; NOTE; OPTIC NERVE TUMOR; PATHOLOGY; PRESCHOOL CHILD; PROGNOSIS; VISUAL ACUITY;

ANTINEOPLASTIC AGENTS; CHILD; CHILD, PRESCHOOL; DIAGNOSTIC IMAGING; FEMALE; GLIOMA; HUMANS; MALE; OPTIC NERVE NEOPLASMS; PROGNOSIS; RADIOTHERAPY, ADJUVANT; VISUAL ACUITY;

EID: 38449104609     PISSN: None     EISSN: 10920684     Source Type: Journal    
DOI: 10.3171/FOC-07/11/E2     Document Type: Article

References (85)

1. Aarabi B, Long DM, Miller NR: Enlarging optic chiasmal glioma with stable visual acuity. Surg Neurol 10:175-177, 1978
2. Ahn Y, Cho BK, Kim SK, Chung YN, Lee CS, Kim IH, et al.: Optic pathway glioma: outcome and prognostic factors in a surgical series. Childs Nerv Syst 22:1136-1142, 2006
3. Allen JC: Initial management of children with hypothalamic and thalamic tumors and the modifying role of neurofibromatosis-1. Pediatr Neurosurg 32:154-162, 2000
4. Alvord EC Jr, Lofton S: Gliomas of the optic nerve or chiasm. Outcome by patients' age, tumor site, and treatment. J Neurosurg 68:85-98, 1988
5. Astrup J: Natural history and clinical management of optic pathway glioma. Br J Neurosurg 17:327-335, 2003
6. Bartels U, Hawkins C, Jing M, Ho M, Dirks P, Rutka J, et al: Vascularity and angiogenesis as predictors of growth in optic pathway/hypothalamic gliomas. J Neurosurg 104 (5 Suppl):314-320, 2006
7. Bianchi-Marzoli S, Brancato R: Tumors of the optic nerve and chiasm. Curr Opin Ophthalmol 5:11-17, 1994
8. Borit A, Richardson EP Jr: The biological and clinical behaviour of pilocytic astrocytomas of the optic pathways. Brain 105:161-187, 1982
9. Capo H, Kupersmith MJ: Efficacy and complications of radiotherapy of anterior visual pathway tumors. Neurol Clin 9:179-203, 1991
10. Carpentieri SC, Waber DP, Pomeroy SL, Scott RM, Goumnerova LC, Kieran MW, et al: Neuropsychological functioning after surgery in children treated for brain tumor. Neurosurgery 52:1348-1357, 2003
11. Combs SE, Schulz-Ertner D, Moschos D, Thilmann C, Huber PE, Debus J: Fractionated stereotactic radiotherapy of optic pathway gliomas: tolerance and long-term outcome. Int J Radiat Oncol Biol Phys 62:814-819, 2005
12. Czyzyk E, Józwiak S, Roszkowski M, Schwartz RA: Optic pathway gliomas in children with and without neurofibromatosis 1. J Child Neurol 18:471-478, 2003
13. Deliganis AV, Geyer JR, Berger MS: Prognostic significance of type 1 neurofibromatosis (von Recklinghausen Disease) in childhood optic glioma. Neurosurgery 38:1114-1119, 1996
14. Desai SS, Paulino AC, Mai WY, Teh BS: Radiation-induced moyamoya syndrome. Int J Radiat Oncol Biol Phys 65:1222-1227, 2006
15. Dutton JJ: Gliomas of the anterior visual pathway. Surv Ophthalmol 38:427-452, 1994
16. Erkal HS, Serin M, Cakmak A: Management of optic pathway and chiasmatic-hypothalamic gliomas in children with radiation therapy. Radiother Oncol 45:11-15, 1997
17. Flickinger JC, Torres C, Deutsch M: Management of low-grade gliomas of the optic nerve and chiasm. Cancer 61:635-642, 1988
18. Fuss M, Hug EB, Schaefer RA, Nevinny-Stickel M, Miller DW, Slater JM, et al: Proton radiation therapy (PRT) for pediatric optic pathway gliomas: comparison with 3D planned conventional photons and a standard photon technique. Int J Radiat Oncol Biol Phys 45:1117-1126, 1999
19. Gayre GS, Scott IU, Feuer W, Saunders TG, Siatkowski RM: Long-term visual outcome in patients with anterior visual pathway gliomas. J Neuroophthalmol 21:1-7, 2001
20. Glaser JS, Hoyt WF, Corbett J: Visual morbidity with chiasmal glioma. Long-term studies of visual fields in untreated and irradiated cases. Arch Ophthalmol 85:3-12, 1971
21. Grabenbauer GG, Schuchardt U, Buchfelder M, Rodel CM, Gusek G, Marx M, et al: Radiation therapy of optico-hypothalamic gliomas (OHG)-radiographic response, vision and late toxicity. Radiother Oncol 54:239-245, 2000
22. Grill J, Couanet D, Cappelli C, Habrand JL, Rodriguez D, Sainte- Rose C, et al: Radiation-induced cerebral vasculopathy in children with neurofibromatosis and optic pathway glioma. Ann Neurol 45:393-396, 1999
23. Grill J, Laithier V, Rodriguez D, Raquin MA, Pierre-Kahn A, Kalifa C: When do children with optic pathway tumors need treatment? An oncological perspective in 106 patients treated in a single centre. Eur J Pediatr 159:692-696, 2000
24. Gururangan S, Fisher MJ, Allen JC, Herndon JE II, Quinn JA, Reardon DA, et al.: Temozolomide in children with progressive low-grade glioma. Neuro Oncol 9:161-168, 2007
25. Hoffman HJ, Humphreys RP, Drake JM, Rutka JT, Becker LE, Jenkin D, et al: Optic pathway/hypothalamic gliomas: a dilemma in management. Pediatr Neurosurg 19:186-195, 1993
26. Horwich A, Bloom HJ: Optic gliomas: radiation therapy and prognosis. Int J Radiat Oncol Biol Phys 11:1067-1079, 1985
27. Hug EB, Muenter MW, Archambeau JO, DeVries A, Liwnicz B, Loredo LN, et al: Conformal proton radiation therapy for pediatric low-grade astrocytomas. Strahlenther Onkol 178:10-17, 2002
28. Jahraus CD, Tarbell NJ: Optic pathway gliomas. Pediatr Blood Cancer 46:586-596, 2006
29. Janss AJ, Grundy R, Cnaan A, Savino PJ, Packer RJ, Zackai EH, et al: Optic pathway and hypothalamic/chiasmatic gliomas in children younger than age 5 years with a 6-year follow-up. Cancer 75:1051-1059, 1995
30. Jenkin D, AngyalfiS, Becker L, Berry M, Buncic R, Chan H, et al.: Optic glioma in children: surveillance, resection, or irradiation? Int J Radiat Oncol Biol Phys 25:215-225, 1993
31. Kadota RP, Kun LE, Langston JW, Burger PC, Cohen ME, Mahoney DH, et al: Cyclophosphamide for the treatment of progressive low-grade astrocytoma: a Pediatric Oncology Group phase II Study. J Pediatr Hematol Oncol 21:198-202, 1999
32. Kestle JR, Hoffman HJ, Mock AR: Moyamoya phenomenon after radiation for optic glioma. J Neurosurg 79:32-35, 1993
33. Khafaga Y, Hassounah M, Kandil A, Kanaan I, Allam A, El Husseiny G, et al: Optic gliomas: a retrospective analysis of 50 cases. Int J Radiat Oncol Biol Phys 56:807-812, 2003
34. King A, Listernick R, Charrow J, Piersall L, Gutmann DH: Optic pathway gliomas in neurofibromatosis type 1: the effect of presenting symptoms on outcome. Am J Med Genet A 122:95-99, 2003
35. Komotar RJ, Burger PC, Carson BS, Brem H, Olivi A, Goldthwaite PT, et al: Pilocytic and pilomyxoid hypothalamic/chiasmatic astrocytomas. Neurosurgery 54:72-80, 2004
36. Komotar RJ, Mocco J, Jones JE, Zacharia BE, Tihan T, Feldstein NA, et al: Pilomyxoid astrocytoma: diagnosis, prognosis, and management. Neurosurg Focus 18(6A): E7, 2005
37. Lacaze E, Kieffer V, Streri A, Lorenzi C, Gentaz E, Habrand JL, et al: Neuropsychological outcome in children with optic pathway tumors when first-line treatment is chemotherapy. Br J Cancer 89:2038-2044, 2003
38. Lama G, Esposito Salsano M, Grassia C, Calabrese E, Grassia MG, Bismuto R, et al: Neurofibromatosis type 1 and optic pathway glioma. A long-term follow-up. Minerva Pediatr 59:13-21, 2007
39. Lancaster DL, Hoddes JA, Michalski A: Tolerance of nitrosureabased multiagent chemotherapy regime for low-grade pediatric gliomas. J Neurooncol 63:289-294, 2003
40. Leonard JR, Perry A, Rubin JB, King AA, Chicoine MR, Gutmann DH: The role of surgical biopsy in the diagnosis of glioma in individuals with neurofibromatosis-1. Neurology 67:1509-1512, 2006
41. Listernick R, Charrow J, Greenwald M, Mets M: Natural history of optic pathway tumors in children with neurofibromatosis type 1: a longitudinal study. J Pediatr 125:63-66, 1994
42. Listernick R, Charrow J, Gutmann DH: Comments on neurofibromatosis 1 and optic pathway tumors. Am J Med Genet 102:105, 2001
43. Listernick R, Charrow J, Gutmann DH: Intracranial gliomas in neurofibromatosis type 1. Am J Med Genet 89:38-44, 1999
44. Listernick R, Darling C, Greenwald M, Strauss L, Charrow J: Optic pathway tumors in children: the effect of neurofibromatosis type 1 on clinical manifestations and natural history. J Pediatr 127:718-722, 1995
45. Listernick R, Ferner RE, Liu GT, Gutmann DH: Optic pathway gliomas in neurofibromatosis-1: controversies and recommendations. Ann Neurol 61:189-198, 2007
46. Listernick R, Ferner RE, Piersall L, Sharif S, Gutmann DH, Charrow J: Late-onset optic pathway tumors in children with neurofibromatosis 1. Neurology 63:1944-1946, 2004
47. Listernick R, Louis DN, Packer RJ, Gutmann DH: Optic pathway gliomas in children with neurofibromatosis 1: consensus statement from the NF1 Optic Pathway Glioma Task Force. Ann Neurol 41:143-149, 1997
48. Liu GT: Optic gliomas of the anterior visual pathway. Curr Opin Ophthalmol 17:427-431, 2006
49. Liu GT, Brodsky MC, Phillips PC, Belasco J, Janss A, Golden JC, et al: Optic radiation involvement in optic pathway gliomas in neurofibromatosis. Am J Ophthalmol 137:407-414, 2004
50. Mahoney DH Jr, Cohen ME, Friedman HS, Kepner JL, Gemer L, Langston JW, et al: Carboplatin is effective therapy for young children with progressive optic pathway tumors: a Pediatric Oncology Group phase II study. Neuro Oncol 2:213-220, 2000
51. Marcus KJ, Goumnerova L, Billett AL, Lavally B, Scott RM, Bishop K, et al: Stereotactic radiotherapy for localized low-grade gliomas in children: final results of a prospective trial. Int J Radiat Oncol Biol Phys 61:374-379, 2005
52. Massimino M, Spreafico F, Cefalo G, Riccardi R, Tesoro-Tess JD, Gandola L, et al: High response rate to cisplatin/etoposide regimen in childhood low-grade glioma. J Clin Oncol 20:4209-4216, 2002
53. Massry GG, Morgan CF, Chung SM: Evidence of optic pathway gliomas after previously negative neuroimaging. Ophthalmology 104:930-935, 1997
54. Medlock MD, Madsen JR, Barnes PD, Anthony DS, Cohen LE, Scott RM: Optic chiasm astrocytomas of childhood. 1. Long-term follow-up. Pediatr Neurosurg 27:121-128, 1997
55. Medlock MD, Scott RM: Optic chiasm astrocytomas of childhood. 2. Surgical management. Pediatr Neurosurg 27:129-136, 1997
56. Menor F, Martí-Bonmatí L, Mulas F, Cortina H, Olagüe R: Imaging considerations of central nervous system manifestations in pediatric patients with neurofibromatosis type 1. Pediatr Radiol 21:389-394, 1991
57. Moghrabi A, Friedman HS, Ashley DM, Bottom KS, Kerby T, Stewart E, et al: Phase II study of carboplatin (CBDCA) in progressive low-grade gliomas. Neurosurg Focus 4(4):E3, 1998
58. Ng YT, North KN: Visual-evoked potentials in the assessment of optic gliomas. Pediatr Neurol 24:44-48, 2001
59. Opocher E, Kremer LC, Da Dalt L, van de Wetering MD, Viscardi E, Caron HN, et al: Prognostic factors for progression of childhood optic pathway glioma: a systematic review. Eur J Cancer 42:1807-1816, 2006
60. Osztie E, Várallyay P, Doolittle ND, Lacy C, Jones G, Nickolson HS, et al: Combined intraarterial carboplatin, intraarterial etoposide phosphate, and IV Cytoxan chemotherapy for progressive optic-hypothalamic gliomas in young children. AJNR Am J Neuroradiol 22:818-823, 2001
61. Packer RJ, Bilaniuk LT, Cohen BH, Braffman BH, Obringer AC, Zimmerman RA, et al: Intracranial visual pathway gliomas in children with neurofibromatosis. Neurofibromatosis 1:212-222, 1988
62. Packer RJ, Savino PJ, Bilaniuk LT, Zimmerman RA, Schatz NJ, Rosenstock JG, et al.: Chiasmatic gliomas of childhood. A reappraisal of natural history and effectiveness of cranial irradiation. Childs Brain 10:393-403, 1983
63. Parsa CF, Hoyt CS, Lesser RL, Weinstein JM, Strother CM, Muci- Mendoza R, et al: Spontaneous regression of optic gliomas: thir- teen cases documented by serial neuroimaging. Arch Ophthalmol 119:516-529, 2001
64. Peng F, Juhasz C, Bhambhani K, Wu D, Chugani DC, Chugani HT: Assessment of progression and treatment response of optic pathway glioma with positron emission tomography using alpha- [(11)C]methyl-L-tryptophan. Mol Imaging Biol 9:106-109, 2007
65. Pepin SM, Lessell S: Anterior visual pathway gliomas: the last 30 years. Semin Ophthalmol 21:117-124, 2006
66. Perilongo G, Moras P, Carollo C, Battistella A, Clementi M, Laverda A, et al: Spontaneous partial regression of low-grade glioma in children with neurofibromatosis-1: a real possibility. J Child Neurol 14:352-356, 1999
67. Petronio J, Edwards MS, Prados M, Freyberger S, Rabbitt J, Silver P, et al: Management of chiasmal and hypothalamic gliomas of infancy and childhood with chemotherapy. J Neurosurg 74: 701-708, 1991
68. Pungavkar SA, Lawande MA, Patkar DP, Agrawal NV, Gadani S: Bilateral optic pathway glioma with intracranial calcification: magnetic resonance imaging and magnetic resonance spectroscopy findings. Australas Radiol 49:489-492, 2005
69. Rush JA, Younge BR, Campbell RJ, MacCarty CS: Optic glioma. Long-term follow-up of 85 histopathologically verified cases. Ophthalmology 89:1213-1219, 1982
70. Serdaroglu A, Simsek F, Gücüyener K, Oguz A, Karadeniz C, Balibey M: Moyamoya syndrome after radiation therapy for optic pathway glioma: case report. J Child Neurol 15:765-767, 2000
71. Sharif S, Ferner R, Birch JM, Gillespie JE, Gattamaneni HR, Baser ME, et al.: Second primary tumors in neurofibromatosis 1 patients treated for optic glioma: substantial risks after radiotherapy. J Clin Oncol 24:2570-2575, 2006
72. Shen TT, Sakai O, Curtin HD, Rizzo JF III: Magnetic resonance imaging of primary anterior visual pathway tumors. Int Ophthalmol Clin 41:171-180, 2001
73. Silva MM, Goldman S, Keating G, Marymont MA, Kalapurakal J, Tomita T: Optic pathway hypothalamic gliomas in children under three years of age: the role of chemotherapy. Pediatr Neurosurg 33:151-158, 2000
74. Suárez JC, Viano JC, Zunino S, Herrera EJ, Gomez J, Tramunt B, et al: Management of child optic pathway gliomas: new therapeutical option. Childs Nerv Syst 22:679-684, 2006
75. Sylvester CL, Drohan LA, Sergott RC: Optic-nerve gliomas, chiasmal gliomas and neurofibromatosis type 1. Curr Opin Ophthalmol 17:7-11, 2006
76. Tao ML, Barnes PD, Billett AL, Leong T, Shrieve DC, Scott RM, et al: Childhood optic chiasm gliomas: radiographic response following radiotherapy and long-term clinical outcome. Int J Radiat Oncol Biol Phys 39:579-587, 1997
77. Taveras JM, Mount LA, Wood EH: The value of radiation therapy in the management of glioma of the optic nerves and chiasm. Radiology 66:518-528, 1956
78. Tenny RT, Laws ER Jr, Younge BR, Rush JA: The neurosurgical management of optic glioma. Results in 104 patients. J Neurosurg 57:452-458, 1982
79. Thiagalingam S, Flaherty M, Billson F, North K: Neurofibromatosis type 1 and optic pathway gliomas: follow-up of 54 patients. Ophthalmology 111:568-577, 2004
80. Tow SL, Chandela S, Miller NR, Avellino AM: Long-term outcome in children with gliomas of the anterior visual pathway. Pediatr Neurol 28:262-270, 2003
81. Trisciuzzi MT, Riccardi R, Piccardi M, Iarossi G, Buzzonetti L, Dickmann A, et al: A fast visual evoked potential method for functional assessment and follow-up of childhood optic gliomas. Clin Neurophysiol 115:217-226, 2004
82. Walker D: Recent advances in optic nerve glioma with a focus on the young patient. Curr Opin Neurol 16:657-664, 2003.
83. WisoffJH: Management of optic pathway tumors of childhood. Neurosurg Clin N Am 3:791-802 1992.
84. Yoshikawa G, Nagata K, Kawamoto S, Tsutsumi K: Remarkable regression of optic glioma in an infant. Case illustration. J Neurosurg 98:1134, 2003
85. Zizka J, Eliás P, Jakubec J: Spontaneous regression of low-grade astrocytomas: an underrecognized condition? Eur Radiol 11: 2638-2640, 2001